Neuronetics sells the NeuroStar magnetic brain stimulation system to healthcare providers for treating depression. STIM reports earnings on Wed, Nov 4, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 11 | B. Riley Securities | Initiated | Buy | |
| Sep 9 | BTIG | Reiterated | Buy | |
| Aug 11 | BTIG | Target raised | Buy | |
| Jul 20 | BTIG | Initiated | Buy |
Seasonality
How STIM has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.
Whale Options Flow
90DNo whale options trades in STIM in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether STIM is in one of them and how their past STIM trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered STIM in an article yet. Here's the latest on the wider market.
About Neuronetics
Neuronetics is a medical technology company based in Malvern, Pennsylvania. Its main product is the NeuroStar Advanced Therapy System, a treatment given in a doctor's office that uses magnetic pulses to stimulate parts of the brain linked to mood. It is used to treat major depression and some related conditions. The company sells the system and its treatment sessions to healthcare providers, and it also runs treatment centers in the United States that offer the therapy to patients.
- Headquarters
- Malvern, PA
- Founded
- 2003
- Website
- neuronetics.com ↗